Results 191 to 200 of about 161,517 (244)

Alpha-interferon induced acute renal allograft rejection [PDF]

, 1995
Holley, JL, Johnson, JP, Jordan, M, Magnone, M, McCauley, J, Scantlebury, V, Shapiro, R, Starzl, T, Vivas, C   +8 more
core  

Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone

Advanced Healthcare Materials, EarlyView.
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li, Andi Dian Permana, Juan Domínguez‐Robles, Muh Nur Amir, Habibie Habibie, Qonita Kurnia Anjani, Li Zhao, Natalia Moreno‐Castellanos, Ryan F Donnelly, Eneko Larrañeta   +9 more
wiley   +1 more source

A Dive Into Cerebellar Dysfunction, Motor Deficits and GABAergic Signaling in Down Syndrome. [PDF]

Cureus
Feely S, Rios Rodriguez M, Shannon A, Young S, Rosales JP, Kaur G.   +5 more
europepmc   +1 more source

Longer Acting Injectable: Continuous, Linear Release of a Progestin Contraceptive From an Oxidized Porous Silicon Host

Advanced Healthcare Materials, EarlyView.
Progestin drugs are loaded into a mesoporous silicon dioxide host by melt‐infiltration. Drugs that decompose at or close to their melting point can be loaded by the addition of cholesterol, which acts as a melting point suppressor. High mass loading of the drug is achieved, and dissolution of the composite is controlled by the nanoscale properties of ...
Geoffrey Hollett, Ruhan Fan, Tushar Kumeria, Heidi Leonard, Byungji Kim, Taylor R. Martin, Irmak Ipekci, Joanna Wang, Jiuk Byun, Nicole A. Chan, Amber Pierron, Curtis E. Moore, Jennifer Ayres, Michael J. Sailor   +13 more
wiley   +1 more source

Retained non-previa placenta in the era of "placenta accreta spectrum": a report of two cases managed expectantly and a proposed plan for management. [PDF]

Front Med (Lausanne)
Ramadan MK, El-Zein N, Jomaa M, Zeidan A, El Tal R, Badr DA.   +5 more
europepmc   +1 more source

An In Situ Curing, Shear‐Responsive Biomaterial Designed for Durable Embolization of Microvasculature

Advanced Healthcare Materials, EarlyView.
NeoCast is a next‐generation, solvent‐free, non‐adhesive liquid embolic designed for indications where deep occlusion is desired (e.g., tumors and chronic subdural hematoma). This novel agent offers ideal embolic properties: injectability, controllability, excellent visibility, and biocompatibility.
Quynh P. Pham, Jeffrey V. Groom II, Chander Sadasivan, David J. Fiorella, David C. Madoff, Lee‐Jae Guo, Michael Fornaciari, Courtney Guertin, Craig Wiltsey, Lee Core, Jonathan Merlo, William Wustenberg, Renu Virmani, Adam S. Arthur, Robert S. Langer, George M. Whitesides, Upma Sharma   +16 more
wiley   +1 more source

On-Demand Controlled Release Multi-Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy. [PDF]

Adv Sci (Weinh)
Liang C, Yang H, Li T, Jiang X, Li X, Gao C, Hou L.   +6 more
europepmc   +1 more source

[Delayed-action tablets prepared from plant mucus].

Acta poloniae pharmaceutica, 1975
openaire   +1 more source

Follow-up and reasons for extended-release naltrexone discontinuation for alcohol use disorder after hospital initiation. [PDF]

BMJ Open Qual
Martin M, Seraydarian M, Gasper J, DeFries T.   +3 more
europepmc   +1 more source

Impact of Chronic Fluoxetine Exposure on Oocyte Development and Reproductive Outcomes in a Mouse Model. [PDF]

Int J Mol Sci
Tkachenko MD, Alyoshina NM, Nikishina YO, Frolova VS, Nikishin DA.   +4 more
europepmc   +1 more source